REDCARE PHARMACY NV/ NL0012044747 /
| 06/11/2024 17:29:31 | Chg. -0.80 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 146.10EUR | -0.54% | 2,832 Turnover: 416,063.60 |
-Bid Size: - | -Ask Size: - | 2.84 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.73 EUR | -83.10% |
| EPS Diluted: | - EUR | -83.10% |
| Revenues per Share: | 93.50 EUR | 41.29% |
| Book Value per Share: | 27.14 EUR | 39.30% |
| Cash Flow per Share: | 3.20 EUR | - |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 1,798.80 EUR | 49.36% |
| Net Income: | -11.60 EUR | -85.06% |
| Operating Cash Flow: | 61.50 EUR | - |
| Cash and Cash Equivalents: | 84.20 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 1.58 | 1.40 |
| P/BV ratio: | 5.43 | 4.83 |
| P/CF Ratio: | 46.11 | 40.98 |
| PEG: | 2.43 | - |
| Earnings Yield: | -0.50% | -0.56% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 2.84 bill. EUR | 2.52 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 1.37 mill. EUR | 1.21 mill. EUR |
| Shares Outstanding: | 19.24 mill. | |
Profitability
| Gross Profit Margin: | 24.48% |
| EBIT Margin: | -0.96% |
| Net Profit Margin: | -0.64% |
| Return on Equity: | -2.22% |
| Return on Assets: | -1.14% |
Financial Strength
| Liquidity I / Cash Ratio: | 37.64% |
| Liquidity II / Quick Ratio: | 83.73% |
| Liquidity III / Current Ratio: | 223.29% |
| Debt / Equity Ratio: | 95.63% |
| Dynam. Debt / Equity Ratio: | 812.03% |
Efficiency
| Employees: | 2,075 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 866,891.57 EUR |
| Net Income / Employee: | -5,590.36 EUR |
| Total Assets / Employee: | 492,337.35 EUR |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
